Evidence map›Paper›PMID 34984100›Full record

ArticleMolecular and clinical oncology2022

Successful

Manabu Hoshi, Naoto Oebisu, Yoichi Ohta, Ayaka Tomimoto, Hiroaki Nakamura

Abstract readCase Reports
In one paragraph

Article in Molecular and clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Manabu HoshiDepartment of Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Naoto OebisuDepartment of Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Yoichi OhtaDepartment of Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Ayaka TomimotoDepartment of Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Hiroaki NakamuraDepartment of Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear cell chondrosarcoma (CCCS) is a rare, low-grade, malignant chondrogenic bone tumour. This tumour commonly affects the epiphysis of long bones, particularly in the proximal femur. The present study reported on the case of a 58-year-old male with right hip pain of five months duration. Plain radiography, magnetic resonance imaging and computed tomography scan revealed the characteristic appearance of chondroid mineralisation in the right femoral head, suggesting typical CCCS. Although biopsy is the gold standard for definite diagnosis prior to treatment, wide resection with removal of the biopsy tract is thought to negatively affect the surgical margin and postoperative hip function. Therefore,

Indexed as

biopsyclear cell chondrosarcomaen bloc resectionfemur head

Identifiers

PMID34984100
PMCPMC8719253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.